Shenzhen Neptunus Bioengineering Co., Ltd. (SHE:000078)

China flag China · Delayed Price · Currency is CNY
3.300
-0.010 (-0.30%)
Mar 10, 2026, 2:05 PM CST
42.86%
Market Cap 8.71B
Revenue (ttm) 27.28B
Net Income (ttm) -1.21B
Shares Out 2.63B
EPS (ttm) -0.46
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 34,070,100
Average Volume 88,431,749
Open 3.260
Previous Close 3.310
Day's Range 3.260 - 3.350
52-Week Range 2.080 - 5.700
Beta 0.29
RSI 41.44
Earnings Date Apr 29, 2026

About SHE:000078

Shenzhen Neptunus Bioengineering Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines, infusion products, and western medicine preparations in China. The company provides oryzanol tablets, chlorpheniramine maleate tablets, estazolam tablets, and rifampicin capsules, as well as technical support for generic drug quality consistency evaluation and other medical research and development work. It also distributes drugs, medical devices, and other medical supplies; and offers value-added services for ho... [Read more]

Sector Healthcare
Founded 1992
Employees 8,264
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000078
Full Company Profile

Financial Performance

In 2024, SHE:000078's revenue was 30.32 billion, a decrease of -16.75% compared to the previous year's 36.42 billion. Losses were -1.19 billion, -29.38% less than in 2023.

Financial Statements

News

There is no news available yet.